Health
Apr 30, 2026 – May 13, 2026
- Longitudinal Study: Medical Cannabis Products Provide Sustained Improvements for Migraine Patients
Other observational studies assessing the use of cannabis products among patients enrolled in the UK Medical Cannabis Registry have reported them to be beneficial for those diagnosed with treatment-resistant epilepsy, cancer–related pain, anxiety, endometriosis, inflammatory bowel disease, hypermobility disorders, insomnia, multiple sclerosis, osteoarthritis, substance use disorders, and inflammatory arthritis, among other conditions.
follow us on
Advertisers | Contact Us | Events | Links | Media Kit | Our Company | Payments Pier
Press Room | Print Cover Stories Archives | Electronic Issues and POH Podcasts Archives | Writer's Guidelines